Lauren Biesbroeck Mccaffrey, MD | |
4225 Roosevelt Way Ne, Seattle, WA 98105-6099 | |
(206) 598-5065 | |
(206) 598-2267 |
Full Name | Lauren Biesbroeck Mccaffrey |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 14 Years |
Location | 4225 Roosevelt Way Ne, Seattle, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104147503 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD60470195 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of Washington | 9032022579 | 1482 |
News Archive
Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus.
People with low-back pain who were given an additional individual two and a half-hour education session with a trained specialist on top of their usual care did better than those given normal care alone.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
Medicare payments for hospitals' inpatient and outpatient services should increase 1%, Medicare's advisory panel recommended Thursday, while pay for evaluation and management in hospitals' outpatient facilities should drop to the amount provided to physicians' offices for such services. The Medicare Payment Advisory Commission voted 16-1 to recommend the 1% update for inpatient and outpatient hospital services for 2013.
› Verified 8 days ago
Entity Name | The Association Of Chrmc And University Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255449963 PECOS PAC ID: 9133032964 Enrollment ID: O20031107000585 |
News Archive
Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus.
People with low-back pain who were given an additional individual two and a half-hour education session with a trained specialist on top of their usual care did better than those given normal care alone.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
Medicare payments for hospitals' inpatient and outpatient services should increase 1%, Medicare's advisory panel recommended Thursday, while pay for evaluation and management in hospitals' outpatient facilities should drop to the amount provided to physicians' offices for such services. The Medicare Payment Advisory Commission voted 16-1 to recommend the 1% update for inpatient and outpatient hospital services for 2013.
› Verified 8 days ago
Entity Name | Kaiser Foundation Health Plan Of Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus.
People with low-back pain who were given an additional individual two and a half-hour education session with a trained specialist on top of their usual care did better than those given normal care alone.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
Medicare payments for hospitals' inpatient and outpatient services should increase 1%, Medicare's advisory panel recommended Thursday, while pay for evaluation and management in hospitals' outpatient facilities should drop to the amount provided to physicians' offices for such services. The Medicare Payment Advisory Commission voted 16-1 to recommend the 1% update for inpatient and outpatient hospital services for 2013.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Lauren Biesbroeck Mccaffrey, MD 1959 Ne Pacific St, Box 356524, Seattle, WA 98195-6524 Ph: (206) 543-5290 | Lauren Biesbroeck Mccaffrey, MD 4225 Roosevelt Way Ne, Seattle, WA 98105-6099 Ph: (206) 598-5065 |
News Archive
Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus.
People with low-back pain who were given an additional individual two and a half-hour education session with a trained specialist on top of their usual care did better than those given normal care alone.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
Medicare payments for hospitals' inpatient and outpatient services should increase 1%, Medicare's advisory panel recommended Thursday, while pay for evaluation and management in hospitals' outpatient facilities should drop to the amount provided to physicians' offices for such services. The Medicare Payment Advisory Commission voted 16-1 to recommend the 1% update for inpatient and outpatient hospital services for 2013.
› Verified 8 days ago
Dr. Fan Liu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4225 Roosevelt Way Ne, Seattle, WA 98105 Phone: 206-543-5290 Fax: 206-543-2489 | |
Ulrike I Ochs, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 | |
Dr. Ravi S Krishnan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-8806 Fax: 206-341-1910 | |
Ms. Ardeth Lazz Dunne, PAC Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1730 Minor Avenue, Ste 1000 Dermatology Associates Pllc, Seattle, WA 98101 Phone: 206-267-2100 Fax: 206-267-2101 | |
Virginia P Sybert, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-616-2135 | |
Dr. Tanya Kaur Greywal, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-520-5000 | |
Dr. Kerrie J. Spoonemore, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3216 Ne 45th Pl, Suite 203, Seattle, WA 98105 Phone: 205-525-1168 Fax: 206-525-1169 |